Publications by authors named "Daniel D Wisselink"
Page 1 of 1
Synopsis of recent research by authors named "Daniel D Wisselink"
- Recent research by Daniel D Wisselink focuses on adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with locally advanced colon cancer, particularly assessing its impact on preventing peritoneal metastases after curative surgery.
- The COLOPEC trial provided 5-year oncological outcomes, revealing that HIPEC, administered alongside systemic chemotherapy, may improve patient prognosis compared to systemic chemotherapy alone.
- Furthermore, analysis of tumor cell proximity to the peritoneal surface offers a new objective method for stratifying colon cancer patients based on their risk for developing peritoneal metastases, addressing inconsistencies in pathological classifications.